These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 37574382)
21. Introduction to Equine Biologic and Regenerative Therapies. Boone L; Peroni J Vet Clin North Am Equine Pract; 2023 Dec; 39(3):419-427. PubMed ID: 37558508 [TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? Taylor SE; Smith RK; Clegg PD Equine Vet J; 2007 Mar; 39(2):172-80. PubMed ID: 17378447 [TBL] [Abstract][Full Text] [Related]
23. Stem cell-based therapies for bone repair. Milner PI; Clegg PD; Stewart MC Vet Clin North Am Equine Pract; 2011 Aug; 27(2):299-314. PubMed ID: 21872760 [TBL] [Abstract][Full Text] [Related]
24. Regenerative Medicine Therapies for Equine Wound Management. Dahlgren LA Vet Clin North Am Equine Pract; 2018 Dec; 34(3):605-620. PubMed ID: 30447771 [TBL] [Abstract][Full Text] [Related]
25. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study. Broeckx SY; Martens AM; Bertone AL; Van Brantegem L; Duchateau L; Van Hecke L; Dumoulin M; Oosterlinck M; Chiers K; Hussein H; Pille F; Spaas JH Equine Vet J; 2019 Nov; 51(6):787-794. PubMed ID: 30815897 [TBL] [Abstract][Full Text] [Related]
26. Stem cells: in theory and practice: veterinarians treating horses, dogs, cats with stem cells as research continues. Burns K J Am Vet Med Assoc; 2011 Feb; 238(4):396-9. PubMed ID: 21320006 [No Abstract] [Full Text] [Related]
27. Equine adipose-tissue derived mesenchymal stem cells and platelet concentrates: their association in vitro and in vivo. Del Bue M; Riccò S; Ramoni R; Conti V; Gnudi G; Grolli S Vet Res Commun; 2008 Sep; 32 Suppl 1():S51-5. PubMed ID: 18683070 [TBL] [Abstract][Full Text] [Related]
28. Basic science and clinical application of stem cells in veterinary medicine. Ribitsch I; Burk J; Delling U; Geißler C; Gittel C; Jülke H; Brehm W Adv Biochem Eng Biotechnol; 2010; 123():219-63. PubMed ID: 20309674 [TBL] [Abstract][Full Text] [Related]
29. Antimicrobial Properties of Equine Stromal Cells and Platelets and Future Directions. Pezzanite LM; Chow L; Dow SW; Goodrich LR; Gilbertie JM; Schnabel LV Vet Clin North Am Equine Pract; 2023 Dec; 39(3):565-578. PubMed ID: 37442729 [TBL] [Abstract][Full Text] [Related]
30. Effect of intrabronchial administration of autologous adipose-derived mesenchymal stem cells on severe equine asthma. Adamič N; Prpar Mihevc S; Blagus R; Kramarič P; Krapež U; Majdič G; Viel L; Hoffman AM; Bienzle D; Vengust M Stem Cell Res Ther; 2022 Jan; 13(1):23. PubMed ID: 35063028 [TBL] [Abstract][Full Text] [Related]
31. Intravenous application of allogenic peripheral blood-derived mesenchymal stem cells: a safety assessment in 291 equine recipients. Broeckx S; Borena BM; Zimmerman M; Mariën T; Seys B; Suls M; Duchateau L; Spaas JH Curr Stem Cell Res Ther; 2014; 9(6):452-7. PubMed ID: 24548143 [TBL] [Abstract][Full Text] [Related]
32. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Guest DJ; Smith MR; Allen WR Equine Vet J; 2010 Oct; 42(7):636-42. PubMed ID: 20840579 [TBL] [Abstract][Full Text] [Related]
33. Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse. Ricco S; Renzi S; Del Bue M; Conti V; Merli E; Ramoni R; Lucarelli E; Gnudi G; Ferrari M; Grolli S Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):61-8. PubMed ID: 24046950 [TBL] [Abstract][Full Text] [Related]
34. Extracellular vesicles from equine mesenchymal stem cells decrease inflammation markers in chondrocytes in vitro. Arévalo-Turrubiarte M; Baratta M; Ponti G; Chiaradia E; Martignani E Equine Vet J; 2022 Nov; 54(6):1133-1143. PubMed ID: 34741769 [TBL] [Abstract][Full Text] [Related]
36. Induced pluripotent stem cell lines derived from equine fibroblasts. Nagy K; Sung HK; Zhang P; Laflamme S; Vincent P; Agha-Mohammadi S; Woltjen K; Monetti C; Michael IP; Smith LC; Nagy A Stem Cell Rev Rep; 2011 Sep; 7(3):693-702. PubMed ID: 21347602 [TBL] [Abstract][Full Text] [Related]
37. Differentiation of equine induced pluripotent stem cells into mesenchymal lineage for therapeutic use. Chung MJ; Park S; Son JY; Lee JY; Yun HH; Lee EJ; Lee EM; Cho GJ; Lee S; Park HS; Jeong KS Cell Cycle; 2019 Nov; 18(21):2954-2971. PubMed ID: 31505996 [TBL] [Abstract][Full Text] [Related]
38. Repeated intra-articular administration of equine allogeneic peripheral blood-derived mesenchymal stem cells does not induce a cellular and humoral immune response in horses. Van Hecke L; Magri C; Duchateau L; Beerts C; Geburek F; Suls M; Da Dalt L; Patruno M; Saunders J; Broeckx SY; Depuydt E; Spaas JH Vet Immunol Immunopathol; 2021 Sep; 239():110306. PubMed ID: 34365135 [TBL] [Abstract][Full Text] [Related]
39. Prospects and Challenges of Induced Pluripotent Stem Cells in Equine Health. Donadeu FX; Esteves CL Front Vet Sci; 2015; 2():59. PubMed ID: 26664986 [TBL] [Abstract][Full Text] [Related]
40. Insights into animal models for cell-based therapies in translational studies of lung diseases: Is the horse with naturally occurring asthma the right choice? Lange-Consiglio A; Stucchi L; Zucca E; Lavoie JP; Cremonesi F; Ferrucci F Cytotherapy; 2019 May; 21(5):525-534. PubMed ID: 30929991 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]